triptolide has been researched along with Leukemia, Myeloid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Guo, X; Liu, Y; Shi, P; Wang, S; Wang, W; Xu, B | 1 |
| Feng, YH; Li, XY; Liu, J; Wang, YF; Wu, QL; Zuo, JP | 1 |
2 other study(ies) available for triptolide and Leukemia, Myeloid
| Article | Year |
|---|---|
Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1α and Nrf2.
Topics: Cell Line, Tumor; Diterpenes; Down-Regulation; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Epoxy Compounds; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Leukemia, Myeloid; NF-E2-Related Factor 2; Phenanthrenes | 2013 |
Triptolide suppresses CD80 and CD86 expressions and IL-12 production in THP-1 cells.
Topics: Antigens, CD; B7-1 Antigen; B7-2 Antigen; Cell Line, Tumor; Diterpenes; Epoxy Compounds; Humans; Immunosuppressive Agents; Interleukin-12; Interleukin-12 Subunit p40; Leukemia, Myeloid; Membrane Glycoproteins; Monocytes; Phenanthrenes; Plants, Medicinal; Protein Subunits; Tripterygium | 2005 |